Lambda light chain Antibody, APC (17-9990-42)
The diagnostic value of kappa/lambda ratios determined by immunohistochemistry in the differentiation of plasma cell myeloma from reactive plasmacytosis Shafieno Y, Izadi B, Khazaei S, Foroughikia M, Hookari S, Nazemi S, Tarlan
The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
Protein Marker Evaluation of Monoclonal Gammopathies | AACC.org
Interpretation of Freelite assays | Wikilite
Understanding Freelite®, the lab test for serum free light chains
jm's Adventure with Multiple Myeloma: Kappa:Lambda Free Light Chains and Beta-2 Microglobulin Serum Results from August 17 2011
Human Ig Lambda Light Chain Antibody MAB100491-100: R&D Systems
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Your Test Results
Quantitation of Kappa and Lambda Light Chains for the Detection of Monoclonal Gammopathy
Untitled
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 57
Kappa and Lambda Light Chains - The Myeloma Crowd
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
Human Ig Lambda Light Chain Antibody MAB10049-100: R&D Systems
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 57
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Comparison of Dako's and Beckman Coulter's anti-Kappa and Lambda light chains antibodies with protocols including 1, 2 or 3
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients | Leukemia
Understanding Freelite®, the lab test for serum free light chains
